APA (7th ed.) Citation

MacNeil, J. R., Su, J. R., Broder, K. R., Guh, A. Y., Gargano, J. W., Wallace, M., . . . Oliver, S. E. (2021). Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021. MMWR: Morbidity & Mortality Weekly Report, 70(17), 651. https://doi.org/10.15585/mmwr.mm7017e4

Chicago Style (17th ed.) Citation

MacNeil, Jessica R., et al. "Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021." MMWR: Morbidity & Mortality Weekly Report 70, no. 17 (2021): 651. https://doi.org/10.15585/mmwr.mm7017e4.

MLA (9th ed.) Citation

MacNeil, Jessica R., et al. "Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021." MMWR: Morbidity & Mortality Weekly Report, vol. 70, no. 17, 2021, p. 651, https://doi.org/10.15585/mmwr.mm7017e4.